Neurim Pharmaceuticals is a drug discovery and development company.

Circadin®– a Prolonged Release Melatonin for insomnia was approved by the EU on 29 June, 2007 for the treatment of primary Insomnia in patients aged 55 years and older.

Neurim Pharmaceuticals has a promising pipeline of New Chemical Entities effective in Central Nervous System disorders. We focus on the diseases of aging with the goal of improving the quality of life the older patient.

Our vision

To establish a leadership position in small molecule drug research and development aimed at improving quality of life of the older patient.